TABR Capital Management’s Eli Lilly LLY Stock Holding History

TABR Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.65M	Sell	1,427 -2	-0.1%	-$2.36K	1.21%	16
2026 Q2	$1.71M	Sell	1,429 -4	-0.3%	-$4.09K	1.46%	13
2026 Q1	$1.32M	Buy	1,433 +4	+0.3%	+$4.06K	1.21%	13
2025 Q4	$1.54M	Buy	1,429 +2	+0.1%	+$1.91K	1.02%	14
2025 Q3	$1.04M	Hold	1,427	–	–	0.71%	16
2025 Q2	$1.11M	Buy	1,427 +1	+0.1%	+$777	0.95%	13
2025 Q1	$1.18M	Buy	1,426 +1	+0.1%	+$832	1.23%	15
2024 Q4	$1.1M	Buy	+1,425	New	+$1.18M	0.96%	15

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

TABR Capital Management's LLY Position: Q3 2026 in Review

TABR Capital Management reduced its Eli Lilly (LLY) stake by 0.14% in Q3 2026, selling an estimated $2.36K and leaving 1,427 shares worth $1.65M. The position accounts for 1.21% of the portfolio, ranked #16.

TABR Capital Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.71M in Q2 2026. 2,008 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

TABR Capital Management held 1,427 shares of Eli Lilly worth $1.65M as of Q3 2026.
TABR Capital Management sold 2 Eli Lilly shares in Q3 2026, an estimated $2.36K.
Eli Lilly made up 1.21% of TABR Capital Management's portfolio in Q3 2026, its #16 holding.
TABR Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
TABR Capital Management's Eli Lilly position peaked at $1.71M in Q2 2026.
2,008 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on TABR Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.